Send your comments and tips to email@example.com
Beth Israel Deaconess Medical Ctr.
Boston Medical Center
Brigham and Women's Hospital
Cambridge Health Alliance
Caritas St. Elizabeth's Medical Ctr.
Children's Hospital Boston
Dana-Farber Cancer Institute
Joslin Diabetes Center
Mass. General Hospital
Mass. Health Law
New England Baptist Hospital
Short White Coat
Tufts-New England Medical Center
UMass Memorial Medical Center
University of Massachusetts
VA Medical Centers
A Healthy Blog
Running A Hospital
Nature Network Boston
SciBos - Corie Lok's blog
Nurse at small
Dr. Gwenn Is In
Healthy Children blog
Other Globe Blogs
Elizabeth Cooney is a health reporter for the Worcester Telegram & Gazette.
Boston Globe Health and Science staff:
Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor.
Short White Coat blogger Ishani Ganguli
Short White Coat blogger Jennifer Srygley
Thursday, July 26, 2007
On the blogs: the new 'valley of death,' controlling healthcare costs
On Nature Network Boston, M. William Lensch, a scientist at Children's Hospital Boston and the Harvard Stem Cell Institute, writes a mournful entry about the gap created when researchers must depend on small foundation grants now that government funding of science -- which helps pay for a sponsoring institution's overhead -- is shrinking. It's a new version of the "valley of death" between academic research and commercialization of a discovery.
"With private grants ... you might be paying for all your own reagents but you are not paying your share for the bench space you have, the light shining down on it, or the salary of who sweeps the floor around it relative to someone with the same amount of grant support from the NIH," he writes. "Dig? Here’s where the Valley of Death comes in."
On WBUR's CommonHealth, John E. McDonough of Health Care For All outlines the predicament facing Massachusetts as it expands access to coverage while costs rise. He questions the objectives of the state Quality and Cost Council, created by the healthcare law.
"The set of goals embraces a popular hypothesis in health policy -- that if we just get quality right, given the documented amount of clinical waste in our system, that’s the magic pill to cure our cost disease. Wouldn’t it be luverly?" he writes. "What if this hypothesis is wrong? What if we do everything quality-wise and costs still rise at destructive, unsustainable rates? Are we willing to consider "R" word - regulation?"